Table 3.

Baseline factors associated with incidence of new cases of inflammatory bowel disease (IBD) between baseline and 5 years (univariable analysis).

VariablesIBD+ vs IBD−
OR (95% CI) or mean (SD)p
mNY criteria at M02.58 (0.88–6.81)0.006
Familial history of IBD3.97 (0.92–13.02)0.032
Psoriasis0 (0–0.73)0.013
SF-36 physical36.75 (8.75) vs 40.34 (9.04)0.047
  • mNY: modified New York criteria; M0: Month 0; SF-36: Medical Outcomes Study Short Form-36 questionnaire.